ECMO Machine Market Development | Industry Report 2021

According to the new market research report ECMO Machine Market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. A number of key players are competing against each other to expand their existing customer base. Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.) are the top three players of the extracorporeal membrane oxygenation (ECMO) machine market. These players jointly accounted for a share of 65% to 70% of the total ECMO machine market in 2015.

Download Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=255167654

The growth of the extracorporeal membrane oxygenation ECMO machine market is expected to be cantered in the Asia-Pacific region. Japan is a mature market for ECMO machines, whereas China and India are emerging markets. The reimbursement policies in Japan encourage the adoption of highly advanced techniques such as ECMO. As a result, the Japanese population receives access to healthcare facilities at affordable costs.

In the Asia-Pacific countries, various conferences are being organized to create awareness of advancements and the emerging usage of ECMO systems. Conferences establish a platform for the exchange of new advancements occurring in the field of ECMO systems. They also offer players the opportunity to showcase their products and communicate with stakeholders, while helping scientists and researchers to exchange experiences and build research relations.

Some of the recent events in the Asia-Pacific region includes Asia-Pacific ELSO Conference 2017 (Australia, October 2017), ECMO Current Challenges and Future Perspectives (India, 2016), Extracorporeal Life Support Organization (ELSO), and Asia Pacific ELSO (APELSO) 2013 Meeting (China, 2013).

Some of the recent events in the Asia-Pacific region includes Asia-Pacific ELSO Conference 2017 (Australia, October 2017), ECMO Current Challenges and Future Perspectives (India, 2016), Extracorporeal Life Support Organization (ELSO), and Asia Pacific ELSO (APELSO) 2013 Meeting (China, 2013).

Get report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255167654

Most of the leading players in the market are pursuing the strategies of approvals, product launches, agreements & partnerships, expansions, and other strategies (rebranding, acquisition, website launch, product development, and market deployment).

Pacemakers Market Development | Industry Report 2023

A pacemaker is a medical device used when the heart is unable to produce electrical impulses naturally. When the heart’s natural pacemaker is defective or when the electrical pathways of the heart are blocked, it can cause irregular heartbeats, as known as arrhythmias. A pacemaker uses electrical pulses to prompt the heart to beat at a normal rate to treat arrhythmias.

The development of implantable micro pacemakers for fetal use is further expected to propel the pacemakers market growth for liquid milk replacers. MarketsandMarkets expects the global pacemakers market to grow from USD 4.4 billion in 2018 to USD 4.9 billion by 2023, at a CAGR of 2% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814

The implanted pacemakers segment, by implantability, is projected to grow at the higher CAGR during the forecast period. These devices are often placed in the chest area, just under the collarbone, to send electrical signals to start or regulate the patient’s heartbeat. The increasing prevalence of CVDs and growing awareness on their long-term impacts, and introduction of MRI compatible & leadless, miniaturized implantable pacemakers are driving the preference for advanced treatment options such as MRI Compatible pacemakers.

The dual-chamber pacemakers segment, by technology, is projected to grow at the highest CAGR during the forecast period. A dual-chamber pacemaker has two leads and can be external or implantable. It connects to both chambers on the right side of the heart—the right atrium and the right ventricles—and can coordinate functions between the atria and ventricles. They are recommended for patients who have symptomatic bradycardia caused by sick sinus syndrome, atrioventricular block, or a combination of both. Due to the higher efficiency and cost-effectiveness of dual-chamber pacemakers in atrioventricular block or sick sinus syndrome over single-chamber which will impact their growth at a significant rate

The MRI compatible pacemakers segment, by type, is projected to grow at the highest CAGR during the forecast period. The development of MRI Compatible pacemakers is a major advancement in the pacemakers market. It is estimated that 75% of patients who currently have an implantable cardiac pacemaker will need MRI scans during their lifetimes. With a focus on catering to end-user demands, most prominent players in this pacemakers market have developed and launched technologically advanced MRI Compatible pacemakers in recent years. Factors such as growing number of patients with implanted pacemakers and the increasing need for MRI scans in the geriatric population, as patients in this age group are also more likely to have cardiac devices such as pacemakers.

The hospitals & cardiac centers segment, by end user, is projected to grow at the highest CAGR during the forecast period. Factors such as the large number of cardiovascular surgical procedures performed in hospitals, improving healthcare infrastructure, and favorable reimbursement scenario are driving the growth of the pacemakers market for hospitals & cardiac centers.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243344814

In terms of geographical coverage, the pacemakers market has been segmented into 4 regions, namely, North America, Asia Pacific (APAC), Europe, RoW (Rest of the World). APAC is projected to record the highest growth rate during the forecast period. This can largely be attributed to the increasing prevalence of CVDs in these countries due to various factors such as increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking.

Sinus Dilation Devices Market Development | Industry Report 2023

According to research report the sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. The growth of the market can be attributed to the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810

Benefits of balloon sinuplasty / sinus dilation over conventional sinus surgeries to drive the growth of sinus dilation devices market

ENT Clinics/In Office
Increasing number of treatable patients in ENT clinics, faster recovery time, cost-effectiveness, and growing preference for minimally invasive techniques are some of the factors driving the growth of this segment. In 2016, out of the 188,000 patients suffering from chronic sinusitis, 160,000 (85%) patients performed the balloon sinus dilation procedure in ENT clinics/in office in the US (Source: Entellus Presentation 2017.

Ambulatory Surgical Centres (ASCs)
Ambulatory surgical centres (ASCs) provide healthcare services and primary care to patients in an outpatient capacity. The minimally invasive procedure such as balloon sinus dilation can be easily performed in ASCs. Factors such as better infrastructure in ASCs are driving the growth of this segment. The cost-effectiveness coupled with the better reimbursement scenario than hospitals is also driving the growth of this segment.

Hospitals
Hospitals is one of the patient care settings where sinus dilation devices are extensively used.
This segment holds the largest market share due to high number of outpatient sinus dilation procedures, the advantages of having integrated healthcare facilities, the availability of technologically advanced infrastructures, and the ability to perform complex sinus surgeries.

North America is expected to dominate the sinus dilation devices market in 2018
In 2018, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to rapidly increasing geriatric population, rising prevalence of chronic sinusitis, higher adoption of new technologies among ENT surgeons and otolaryngologists, favorable reimbursement scenario, and the presence of major players in this region.

Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=64349810

Key players in the Sinus Dilation Devices Market include The major players in the market are Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China) and dalENT Medical (US). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the sinus dilation devices market.

eHealth Market Development | Industry Report 2023

According to the new market research report eHealth Market is expected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%.
Factors such as the growing need to manage regulatory compliance through the use of eHealth solutions, the need to curtail escalating healthcare costs, increasing government initiatives supporting the use of eHealth solutions and services, the high prevalence of chronic diseases, shift towards patient-centric healthcare delivery, and rising usage of big data are majorly driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143

Based on product and service, the eHealth market is segmented into eHealth solutions and eHealth services. The eHealth services segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as the rising demand for availing medical consultation online, rapidly emerging new technologies in healthcare, the demand for home healthcare services, and the use of telecommunication and multimedia technologies combined within mobile and wireless healthcare delivery systems.

By type of eHealth solutions, the chronic care management apps are expected to register the highest CAGR during the forecast period. This can be attributed to the growing incidence of chronic diseases, high penetration of mobiles, and increasing adoption of mHealth solutions owing to various benefits such as ease of use and reduced costs offered by these solutions across the globe.

Based on type of eHealth services, the remote monitoring services segment is expected to register the highest CAGR during the forecast period. This can be attributed to the increasing incidence of chronic diseases across the globe and the widespread preference of patients for home healthcare and rehabilitation due to the convenience of these services.

Based on end user, the healthcare consumers segment is expected to register the highest CAGR during the forecast period. Factors such as the rising demand for personalized care, increased awareness for telehealth services, and high penetration of digital technologies among consumers are contributing to the high adoption of eHealth solutions among healthcare consumers.

The Asia Pacific region is expected to register the highest growth rate in the global eHealth market during the forecast period. Growing medical tourism, growing consumerism in the healthcare industry, accelerated economic growth of countries in the region, the implementation of new ICT guidelines, and the implementation of eHealth programs are the factors propelling the growth of the market in this region.

Get Sample Pages: https://www.marketsandmarkets.com/requestsample.asp?id=11513143

Emerging markets such as China, India, and Australia have a high potential for growth in the eHealth market mainly due to the rising government investments and reforms to modernize healthcare infrastructure, growing purchasing power of consumers, increasing government initiatives for infrastructural development, and the rising need to control the soaring healthcare costs. In addition, as the patient population in China and India is large and diverse, population health management through the use of effective eHealth solutions and services plays a central role in providing cost-effective and quality clinical care to patients, thereby further generating a significant growth opportunity for the players competing in the global eHealth during the forecast period.

Clinical Microbiology Market Development | Industry Report 2023

According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period.
Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367

Market Size Estimation
A detailed market estimation approach was followed to estimate and validate the size of the clinical microbiology market and other dependent submarkets, as mentioned above. The key players in the clinical microbiology market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. Research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the clinical microbiology market. All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.

The global clinical microbiology market is segmented by product, disease area, end user, and region. On the basis of products, the clinical microbiology market is segmented into instruments, and reagents.

estimate the market size includes the following:
• The key players in the industry and markets have been identified through extensive secondary research.
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219135367

Geographically, Asia Pacific market is expected to grow at the highest CAGR from 2018 to 2023. Key factors driving the growth of the market in APAC are the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence of infectious diseases in the region.

Biopsy Devices Market Top Players and Growth Strategies | Industry Report 2022

According to research report the biopsy devices market is expected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a CAGR of 6.8% from 2017 to 2022.

The report analyzes the global biopsy devices market by product, guidance technique, application, end user, and region. Based on product, the global market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products (forceps, markers, probes, punches, curettes, and sutures). In 2016, the needle-based biopsy instruments segment accounted for the largest share of global market mainly due to the increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132886515

Based on application, the global market is segmented into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. The breast biopsy segment accounted for the largest share of the global market in 2016. The rising prevalence of breast cancer and growing awareness about the disease are driving market growth in this segment.

Based on guidance technique, the biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging (MRI)-guided biopsy, and other guidance techniques (positron emission tomography, fluoroscopy, and thermography). In 2016, the ultrasound biopsy segment dominated the market.

Based on end user, the market is segmented into hospitals, diagnostic & imaging centers, and academic & research institutes. In 2016, hospitals formed the largest end-user segment of the market. This can be attributed to the growth in the healthcare sector in emerging economies along with the increase in the out-of-pocket healthcare expenditure and increase in the number of hospitals.

Players in the global biopsy devices market, such as Becton, Dickinson and Company (U.S.), Devicor Medical Products, Inc. (U.S.), Argon Medical Devices, Inc. (U.S.), Cardinal Health, Inc. (U.S.), and Boston Scientific Corporation (U.S.) are focusing on increasing their presence in the high-growth markets through agreements, expansions, and acquisitions. Olympus Corporation (Japan), Cook Group Incorporated (U.S.), and Boston Scientific Corporation (U.S.) are some of the players focusing on organic growth strategy of new product launches to enhance their market presence.

C. R. Bard dominated the market due to its broad biopsy devices product portfolio. It operates in around 100 countries outside the U.S. The company manufactures medical devices in the field of vascular therapy, urology, oncology, and surgical specialties. C. R. Bard has a wide product portfolio for biopsy, including vacuum-assisted devices, core needle biopsy products, localization wires, breast tissue markers, and probes.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132886515

Becton, Dickinson and Company is another prominent player in the market. The company is engaged in the development, manufacturing, and marketing of medical devices, instrument systems, and reagents. BD operates through two business segments—BD Medical and BD Life Sciences. The company offers biopsy products through its medication and procedural solutions segment, which operates under its Medical division.

Interventional Cardiology Devices Market Development | Industry Report 2022

According to research report the interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%.

Interventional cardiology devices are devices that are used to unclog blood vessels and restore normal blood flow. The market for these devices is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5% during the forecast period. Growth in this market is mainly driven by factors such as the rapidly increasing geriatric population and technological advancements in interventional cardiology devices.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548

Other factors supporting market growth include the increasing incidence of cardiovascular diseases, rising healthcare expenditure in emerging, improving healthcare infrastructure across the globe.
On the basis of type, the interventional cardiology devices market is categorized into angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, and other interventional cardiology devices. The plaque modification devices segment is expected to register the highest growth during the forecast period. Growth in this market is mainly due to the increasing adoption of these devices for plaque removal in arteries due to their effectiveness.

The angioplasty stents market is further segmented into bare-metal stents, drug-eluting stents, and bioresorbable stents. The bioresorbable stents segment is estimated to register the highest growth during the forecast period. Growth in this segment can be attributed to the benefits associated with the use of these stents, such as the dissolvability feature which minimizes the risk of restenosis after the interventional procedure.

The other interventional cardiology devices market is further classified into guidewires, vascular closure devices, introducer sheaths, and balloon inflation devices. The vascular closure devices segment is estimated to grow at the highest rate during the forecast period. The increasing demand for vascular closure in minimally invasive interventional cardiology procedures and technological advancements in these devices are driving the demand for vascular closure devices in the other interventional cardiology devices segment.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=548

The interventional cardiology devices market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia Pacific is expected to register the highest growth due to the improving healthcare infrastructure, the heavy burden of cardiovascular diseases, rising healthcare expenditure, and growth in the demand for interventional cardiology devices.
Given the immense opportunities in the major applications of interventional cardiology devices, market leaders and emerging players are increasingly focusing on the market in the segments mentioned above to increase their revenues and are also looking to expand their reach to emerging economies